Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.2K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

531
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
531
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

821
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
821
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Sleep Apnea01:21

Sleep Apnea

747
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
747
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

3.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermittent exposure to high-altitude work: nocturnal hypoxemia sea-level anthropometric and biochemical markers.

Sleep & breathing = Schlaf & Atmung·2026
Same author

Home blood pressure trajectories during 3 months of continuous positive airway pressure therapy in sleepy vs. non-sleepy patients.

Annals of the American Thoracic Society·2026
Same author

Recent Advances in Sleep and Circadian Characteristics in Eating Disorders: A Systematic Review of the Last Five Years (2020-2025).

Nature and science of sleep·2026
Same author

Single-beat right ventricular-pulmonary artery coupling and residual heart failure in patients with a HeartMate 3 left ventricular assist device.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Obstructive sleep apnea and cardiac arrest in hypertrophic cardiomyopathy: An analysis of the nationwide inpatient sample database.

Progress in cardiovascular diseases·2026
Same author

Multidisciplinary Management and Hemodynamic Rescue of Cardiogenic Shock in RCA STEMI With Severe Mitral Regurgitation.

JACC. Case reports·2026

Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

3.8K

Heart failure and sleep disorders.

Gianfranco Parati1,2,3, Carolina Lombardi1,2, Francesco Castagna1,2,4

  • 1Department of Cardiovascular, Neural, and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano, Piazza Brescia 20, 20149 Milan, Italy.

Nature Reviews. Cardiology
|May 14, 2016
PubMed
Summary

Sleep-disordered breathing, including obstructive sleep apnea (OSA) and central sleep apnea (CSA), is common in heart failure (HF) patients. Treatments for HF can improve these sleep conditions, with more evidence supporting OSA treatment benefits.

More Related Videos

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.6K
Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
10:56

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice

Published on: August 2, 2017

10.6K

Related Experiment Videos

Last Updated: Mar 21, 2026

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

3.8K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.6K
Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
10:56

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice

Published on: August 2, 2017

10.6K

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Pulmonology

Background:

  • Sleep-related disorders are increasingly recognized in cardiovascular disease patients.
  • Heart failure (HF) patients frequently report sleep-disordered breathing (SDB), short sleep duration, and poor sleep quality.
  • SDB, encompassing obstructive sleep apnea (OSA) and central sleep apnea (CSA), is prevalent in HF and linked to increased morbidity and mortality.

Purpose of the Study:

  • To review the association between sleep-disordered breathing and heart failure.
  • To discuss the impact of SDB on cardiovascular health.
  • To explore the effects of HF treatments on SDB.

Main Methods:

  • Literature review of studies on sleep-disordered breathing in heart failure patients.
  • Analysis of the pathophysiological mechanisms linking SDB and HF.
  • Examination of the impact of various HF therapies on OSA and CSA.

Main Results:

  • Both OSA and CSA are associated with sympathetic activation, altered hemodynamics, and hypoxemia.
  • OSA is strongly linked to hypertension, a major risk factor for cardiac hypertrophy and failure.
  • HF treatments like specific medications, exercise, cardiac resynchronization therapy, and heart transplantation can reduce OSA and CSA severity.

Conclusions:

  • HF treatments demonstrate positive effects on both OSA and CSA.
  • While the optimal treatment for CSA in HF remains debated, evidence supports the benefits of OSA treatment in HF patients.